ライフサイエンスコーパス: hip arthroplasty

1 high risk for DVT (eg, recent total knee or hip arthroplasty).

2 ed following knee arthroplasty compared with hip arthroplasty.

3 roplasty and 0.26% (95% CI, 0.14%-0.37%) for hip arthroplasty.

4 roplasty and 0.14% (95% CI, 0.07%-0.21%) for hip arthroplasty.

5 sty and 348,596 who underwent revision total hip arthroplasty.

6 ht-sided hip pain, before and 9 months after hip arthroplasty.

7 tomatic events, in patients undergoing total hip arthroplasty.

8 ury, as well as patients undergoing elective hip arthroplasty.

9 nidine was used in patients undergoing total hip arthroplasty.

10 s between minimal and standard incisions for hip arthroplasty.

11 ity and morbidity following elective knee or hip arthroplasty.

12 between ethnic groups are not seen following hip arthroplasty.

13 R 1.22, 95% CI 0.63-2.36 in Hispanics) after hip arthroplasty.

14 omboembolism within three months after total hip arthroplasty.

15 patients who had previously undergone total hip arthroplasty.

16 in both groups were cholecystectomy (10.5%), hip arthroplasty (10.5%), spine surgery (9.8%), herniorr

17 e groups of patients: 14 who were undergoing hip arthroplasty, 28 hemodialysis patients who were part

18 In patients who underwent total hip arthroplasty, a body-mass index of 25 or greater was

19 We describe the epidemiology of knee and hip arthroplasties among centenarians using data from a

20 Overall, there were 679 hip arthroplasties and 7 knee arthroplasties among cente

21 increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001).

22 A beneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision tota

23 these thalamic volume changes reverse after hip arthroplasty and are associated with decreased pain

24 f venous thromboembolism is high after total hip arthroplasty and could persist after hospital discha

25 ients older than 10 years, 19 required total hip arthroplasty and none improved.

26 fails, to guide the child and family through hip arthroplasty and rehabilitation.

27 zation (range: 61% for TURP to 88% for total hip arthroplasty), and are thus missed by the ProPublica

28 rtic aneurysm (AAA) repair, colectomy, total hip arthroplasty, and pancreatectomy.

29 esults of both cemented and cementless total hip arthroplasty at mid- to long-term follow-up.

30 ficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decr

31 ication codes for primary and revision total hip arthroplasty between 1991 and 2008.

32 Total hip arthroplasty continues to be an extremely successful

33 have been used in dental implants and total hip arthroplasty due to their excellent biocompatibility

34 infection (SSI) is a feared complication in hip arthroplasty, especially following femoral neck frac

35 Future demand for hip arthroplasty, especially in patients younger than 65

36 All subjects had undergone total hip arthroplasty for idiopathic arthritis, and the scans

37 new radiographic finding of hip OA or total hip arthroplasty for OA (OR 1.71, 95% CI 1.16-2.52, P =

38 om 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001).

39 ements in orthopedic surgery, the results of hip arthroplasty have improved.

40 was borderline statistically significant for hip arthroplasty (HR 0.73 [95% CI 0.52-1.03], P = 0.07),

41 ar tissues from people with metal-on-polymer hip arthroplasties, immunohistochemically.

42 an age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and f

43 Total hip arthroplasty is a common surgical procedure but litt

44 Total hip arthroplasty is a cost-effective surgical procedure

45 For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 d

46 mptomatic venous thromboembolism after total hip arthroplasty most commonly develops after the patien

47 ared to failed Metal-on-Polymer articulating hip arthroplasties (n = 10).

48 r surgery (fracture groups, n = 33) or total hip arthroplasty (nonfracture groups, n = 17).

49 rthroplasty and 6,703 patients who underwent hip arthroplasty over a 5-year period were analyzed.

50 The proportion of primary total hip arthroplasty patients discharged home declined from

51 me allograft bone donated from primary total hip arthroplasty recipients must be discarded or treated

52 A vast majority (83%) of hip arthroplasty recipients were women.

53 The newer cementless hip arthroplasties showed evidence of learning curve, pa

54 For revision total hip arthroplasty, similar trends were observed in hospit

55 a low of 0.005 for "Procedure-Targeted Total Hip Arthroplasty Surgical Site Infection." Generally, re

56 uch parameters and the 19-year risk of total hip arthroplasty (THA) for end-stage OA.

57 rrowing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the f

58 and predictors of prognosis following total hip arthroplasty (THA) for osteoarthritis (OA).

59 irty-day readmission to hospital after total hip arthroplasty (THA) has significant direct costs and

60 of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial.

61 tal of 108 men and women scheduled for total hip arthroplasty (THA) or total knee arthroplasty (TKA)

62 hospitals' SSI rates following primary total hip arthroplasty (THA) or total knee arthroplasty (TKA).

63 f dislocation and aseptic loosening in total hip arthroplasty (THA).

64 In muscle of patients who were undergoing hip arthroplasty, the 14-kD actin fragment level was cor

65 throplasty (TPKA) and after total or partial hip arthroplasty (TPHA) are proposed patient safety indi

66 rquartile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following

67 Rates of total knee or hip arthroplasty were found to be substantially lower am

68 patients scheduled to undergo elective total hip arthroplasty were randomly assigned, stratified acco

69 holecystectomy, partial colectomy, and total hip arthroplasty were used.

70 reviewed in a cohort of 58 patients with 66 hip arthroplasties with Rejuvenate stems who had present

71 llowing knee arthroplasty and 0.7% following hip arthroplasty, with no significant differences by rac